We are live on ! Find out more
RDY icon

Dr. Reddy's Laboratories
RDY

152 hedge funds and large institutions have $796M invested in Dr. Reddy's Laboratories in 2019 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 51 increasing their positions, 53 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,691% more call options, than puts

Call options by funds: $394K | Put options by funds: $22K

13% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 16

1% more funds holding

Funds holding: 150 → 152 (+2)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

2% less capital invested

Capital invested by funds: $812M → $796M (-$16.1M)

4% less repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 53

2.03% less ownership

Funds ownership: 65.23% → 63.2% (-2%)

Holders
152
Holders Change
+2
Holders Change %
+1.33%
% of All Funds
3.33%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
18
Increased
51
Reduced
53
Closed
16
Calls
$394K
Puts
$22K
Net Calls
+$372K
Net Calls Change
+$342K

Top Buyers

Rank Fund Capital Flow
1
Mitsubishi UFJ Trust & Banking
Mitsubishi UFJ Trust & Banking
Japan
+$15.9M
2
Goldman Sachs
Goldman Sachs
New York
+$10.9M
3
Renaissance Technologies
Renaissance Technologies
New York
+$10.4M
4
Marshall Wace
Marshall Wace
United Kingdom
+$5.42M
5
MWNA
Marshall Wace North America
New York
+$5.32M

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$9.2M
2
Swiss National Bank
Swiss National Bank
Switzerland
-$5.31M
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$4.79M
4
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$4.63M
5
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO)
Massachusetts
-$3.96M
Name Holding Trade Value Shares
Change 		Change in
Stake
PAM
26
Panagora Asset Management
Massachusetts
$5.8M +$1.38M +185,275 +32%
MWNA
27
Marshall Wace North America
New York
$5.73M +$5.32M +714,585 +1,706%
Marshall Wace
28
Marshall Wace
United Kingdom
$5.52M +$5.42M +728,090 New
TD Asset Management
29
TD Asset Management
Ontario, Canada
$5.22M – – –
Schroder Investment Management Group
30
Schroder Investment Management Group
United Kingdom
$5.14M +$1.21M +162,085 +33%
N
31
Nuveen
North Carolina
$4.86M +$73.7K +9,905 +2%
Sumitomo Mitsui Trust Group
32
Sumitomo Mitsui Trust Group
Japan
$4.38M +$4.3M +577,550 New
JP Morgan Chase
33
JP Morgan Chase
New York
$4.36M +$4.28M +575,395 New
O
34
Ossiam
France
$4M +$2.03M +273,220 +107%
CAM
35
ClariVest Asset Management
California
$3.86M – – –
DZ Bank
36
DZ Bank
Germany
$3.69M – – –
SEI Investments
37
SEI Investments
Pennsylvania
$3.42M +$27.9K +3,755 +0.8%
Wells Fargo
38
Wells Fargo
California
$3.08M -$4.57K -615 -0.2%
DWA
39
Dorsey Wright & Associates
California
$3.02M -$42.7K -5,740 -1%
BNP Paribas Financial Markets
40
BNP Paribas Financial Markets
France
$3.02M -$251K -33,700 -8%
CS
41
Credit Suisse
Switzerland
$2.92M +$1.01M +135,675 +54%
Deutsche Bank
42
Deutsche Bank
Germany
$2.76M -$638K -85,750 -19%
Prudential Financial
43
Prudential Financial
New Jersey
$2.69M -$2.35M -316,000 -47%
OAM
44
Oxford Asset Management
United Kingdom
$2.4M -$1.55M -208,920 -40%
Lazard Asset Management
45
Lazard Asset Management
New York
$2.38M +$150K +20,190 +7%
NVCHI
46
New Vernon Capital Holdings II
New Jersey
$2.24M – – –
Millennium Management
47
Millennium Management
New York
$2.24M +$2.2M +295,450 New
UBS Group
48
UBS Group
Switzerland
$2.15M -$38.2K -5,135 -2%
AAMU
49
Amundi Asset Management US
Massachusetts
$2.05M +$124K +16,680 +7%
NMC
50
Nine Masts Capital
Hong Kong
$1.96M +$1.9M +255,250 New
1
2
3 4 5

RDY Hedge Fund Activity: Q3 2019 in Review

152 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Dr. Reddy's Laboratories (RDY) for Q3 2019, worth a combined $796M — down 2% from $812M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new RDY positions and 16 closed out — a net gain of 2 holders — while 51 added to existing stakes and 53 trimmed.

The largest buyer was Mitsubishi UFJ Trust & Banking, adding an estimated $15.9M. The largest seller was BlackRock, cutting an estimated $9.2M.

  • 152 institutional investors held Dr. Reddy's Laboratories (RDY) as of Q3 2019, up from 150 in Q2 2019.
  • Funds reported $796M of Dr. Reddy's Laboratories stock for Q3 2019, down 2% quarter-over-quarter.
  • 18 funds opened new Dr. Reddy's Laboratories positions in Q3 2019 and 16 closed out, a net change of +2 holders.
  • The largest Dr. Reddy's Laboratories buyer in Q3 2019 was Mitsubishi UFJ Trust & Banking, an estimated $15.9M added.
  • The largest Dr. Reddy's Laboratories seller in Q3 2019 was BlackRock, an estimated $9.2M sold.

Based on aggregated 13F filings for Q3 2019.